39 results
8-K
EX-4.2
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
as Stockholder Until Exercise; No Settlement in Cash. This Preferred Investment Option does not entitle the Holder to any voting rights, dividends
8-K
EX-4.1
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
.
Section 5. Miscellaneous.
a) No Rights as Stockholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends
8-K
EX-4.3
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
Investment Option does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof
8-K
EX-4.1
INM
InMed Pharmaceuticals Inc
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
to any voting rights, dividends or other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except
8-K
EX-4.2
77bkj3lvcxe8pg
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
8-K
EX-4.3
si0iw9s5yt0 ox
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
8-K
EX-4.1
g9pp9y blh
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-4.3
ztg6dv06b8fkrgh
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-4.2
3zcwgs l8p
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-4.1
h0ms otcsz81j40m2z
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-4.2
niv p8p7l
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-4.3
1g69pbrs9qid4epunwg
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
424B5
lsikmnj68qeh 7tpv0va
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
1jxqj0ui3pix e39q
25 Apr 22
Prospectus supplement
5:02pm
424B3
vr942db81hfbq12a3c
7 Apr 22
Prospectus supplement
4:46pm
S-3
9dxt4 t6qf37j
4 Feb 22
Shelf registration
4:36pm
DEF 14A
6g8bfl8z8r8jdi19e0
28 Oct 21
Definitive proxy
3:07pm